Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. The firm currently has a $100.00 price target on the biopharmaceutical company’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 5.44% […]
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) – Equities research analysts at SVB Leerink issued their Q2 2022 earnings per share (EPS) estimates for Horizon Therapeutics Public in a note issued to investors on Sunday, May 22nd. SVB Leerink analyst D. Risinger forecasts that the biopharmaceutical company will post earnings per share of $1.33 […]
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) CEO Timothy P. Walbert sold 25,000 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $90.00, for a total value of $2,250,000.00. Following the transaction, the chief executive officer now directly owns 460,549 shares […]
Horizon Therapeutics plc has formally opened its new global corporate headquarters in Dublin, Ireland. The offices are located in a landmark building at 70 St. Stephen's Green. The 62,000 square foot facility is LEED Gold certified. Horizon’s global headquarters have been in Dublin since 2014 and now employs approximately 200 people in Ireland across a
Horizon Therapeutics plc has formally opened its new global corporate headquarters in Dublin, Ireland. The offices are located in a landmark building at 70 St. Stephen's Green. The 62,000 square foot facility is LEED Gold certified. Horizon’s global headquarters have been in Dublin since 2014 and now employs approximately 200 people in Ireland across a